announced today that Eisai has obtained the approval of additional dosage and administration in Japan of the proton pump inhibitor
Pariet 5 mg Tablets and 10 mg Tablets (generic name: rabeprazole sodium) to administer 10 mg of rabeprazole sodium per dose twice-daily for the maintenance therapy of proton pump inhibitor
-resistant reflux esophagitis (reflux esophagitis in which it is difficult to achieve satisfactory therapeutic effects by existing treatment with once-daily dosing of proton pump inhibitors
Appropriateness of proton pump inhibitor
recommendations at hospital discharge and continuation in primary care.
Factors influencing compliance in long-term proton pump inhibitor
therapy in general practice.
One aspect of the study analysis suggests twice-daily proton pump inhibitor
dosing was associated with a 46% higher risk of chronic kidney disease than once-daily dosing, which was associated with a 15% higher risk.
Association between proton pump inhibitor
therapy and Clostridium difficile infection in a meta-analysis.
They suggested that blocking this pathway by complete acid suppression with a proton pump inhibitor
, may reduce the risk of the cancer.
VIMOVO is a fixed-dose combination of delayed-release enteric-coated naproxen, a non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole, a stomach acid-reducing proton pump inhibitor
This concomitant therapy consists of a proton pump inhibitor
, amoxicillin hydrate (generic name; marketed under two brand names), and either clarithromycin (generic named: marketed under two brand names) or metronidazole (generic name; marketed under one brand name).
Taking a protease inhibitor or a proton pump inhibitor
(a drug that controls stomach acid) was linked to a higher risk of hip, spine, or upper arm fractures in a large study of HIV-positive US male veterans.
Of these 26,000 adults, 12 percent received a proton pump inhibitor
with or without an H2-receptor antagonist for at least two years; 4.
Patients and Methods: Endoscopically diagnosed cases of duodenal ulcer were assigned to two groups where one group received herbal medicine and the other received proton pump inhibitor
for 4 weeks (Clarithromycin and Amoxicillin were added for a week for Helicobacter pylori positive cases).
A proton pump inhibitor
discovered by Takeda Pharmaceutical, Takepron is marketed in over 90 countries worldwide.